UbiVac Information
Contact top employees from
UbiVac
Summary
UbiVac is a private company that has been in the industry for 20 years. The company currently specializes in the Biotechnology area. The position of the President & CEO is occupied by Bernard A. Fox. Its headquarters is located at Portland, Oregon, USA. The number of employees ranges from 25 to 100. The annual revenue of UbiVac varies between 5.0M and 25M. Total funding of the company - $2.1M. To connect with UbiVac employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
10-50 employees
Specialties
Biotechnology, Immunotherapy, Vaccines
SIC Code
2836
DMA Code
Portland Metropolitan Area
Founded
2005
Estimated Annual Revenue
$5.0M - 25M
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2009 | Privately Held | 25 - 100 | 5.6M | $197.7M | |
| 1987 | Public Company | 500 - 1.0K | 928.5M | $2.3B |
Employees Turnover 2 quarter 2025
Length of Employment
Employee tenure at UbiVac shows a diverse range of experience levels:
6% for 1–2 years19% for 3–4 years25% for 5–7 years6% for 8–10 years44% have over 11 years of service at UbiVacContact top employees from
UbiVac
Bernard Fox PhD
Co-Founder / President / CEO
Bernie Fox
Chief Financial & Development Officer
Christopher Paustian
Scientist
Glenna McDonnell
Process Development Associate
Patricia Lin
Quality Control & Research Assistant
